Ocular Therapeutix, Inc. — Balance Sheet Charts
8 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+76.5% +$350M
$808M
Current Assets↑+77.4% +$341M
$782M
Cash & Equivalents↑+88.0% +$345M
$737M
Receivables↓-5.4% -$2M
$31M
Inventory↑+17.2% +$524K
$4M
Net PPE↑+109.6% +$10M
$20M
Total Liabilities↑+7.8% +$11M
$154M
Current Liabilities↑+22.9% +$9M
$51M
Account Payables↓-0.5% -$22K
$4M
Long-Term Debt
—
Stockholders Equity↑+107.5% +$339M
$654M
Retained Earnings↓-29.8% -$266M
$-1.16B
Operating Lease ROU Asset↓-22.0% -$1M
$5M
Operating Lease Liability↑+5.4% +$287K
$6M
Gross PP&E↑+42.9% +$14M
$47M
Accumulated Depreciation↑+16.5% +$4M
$28M
Inventory Raw Materials↓-5.6% -$12K
$202K
Inventory WIP↑+15.6% +$232K
$2M
Inventory Finished Goods↑+22.7% +$304K
$2M
Total Debt Carrying Amount
—
Contract Liability↓-0.9% -$128K
$14M
Contract Liability (Current)↓-75.7% -$199K
$64K
Contract Liability (Noncurrent)↑+0.0% +$0
$14M